...
首页> 外文期刊>Malaria Journal >Clinical relevance of different biomarkers in imported plasmodium falciparum malaria in adults: a case control study
【24h】

Clinical relevance of different biomarkers in imported plasmodium falciparum malaria in adults: a case control study

机译:成人进口恶性疟原虫疟疾中不同生物标志物的临床相关性:病例对照研究

获取原文
           

摘要

Background For rapid initiation of anti-malarial treatment and prevention of complications, early diagnosis and risk stratification is important in patients with Plasmodium falciparum malaria. Routine laboratory values do not correlate well with disease severity. The aim of this study was to determine the diagnostic and prognostic value of several biomarkers related to inflammation; endothelial and cardiac dysfunction; coagulation, and haemolysis in imported P. falciparum malaria. Methods In a prospective case-control study, 79 adult travellers with both uncomplicated and complicated P. falciparum malaria were included between 2007 and 2011. Forty-one healthy subjects were included as controls. Blood samples were obtained within 24 hours after first consultation to assess routine laboratory values as well as markers related to inflammation (PAPP-A, copeptin, CRP), endothelial activation (MPO, elastase-2, endothelin-1, sICAM-1, sVCAM-1), cardiac function (NT-proBNP, MR-proANP), coagulation (fibrinogen, D-dimers, platelet count), and haemolysis (LDH). Prognostic performance was assessed using the receiver operating characteristic curve (area under the curve = AUROC). Results Twelve (15.2%) patients had severe P. falciparum malaria. In the patient group, significant thrombocytopaenia was found, all other markers but PAPP-A were significantly elevated. Diagnostic performance was best for CRP with an AUROC of 1.00, followed by MPO (0.99), D-dimers (0.98), elastase-2 (0.98), and sICAM-1 (0.98). Biomarker levels did not correlate well with disease severity. Conclusion The combination of travel history, fever prior to blood sampling, and CRP serum levels above or below 10.8 mg/l upon hospital admission, best discriminated between malaria patients and control persons. None of the biomarkers studied predicted the presence or the development of malaria complications, neither at the time of admission, nor during hospitalization.
机译:背景技术为了快速启动抗疟疾治疗和预防并发症,对于恶性疟原虫疟疾患者,早期诊断和风险分层很重要。常规实验室值与疾病严重程度没有很好的相关性。这项研究的目的是确定几种与炎症有关的生物标志物的诊断和预后价值。内皮和心脏功能障碍;进口恶性疟原虫的血液凝结和溶血。方法在一项前瞻性病例对照研究中,2007年至2011年间纳入了79例患有简单和复杂恶性疟原虫疟疾的成年旅行者。将41名健康受试者作为对照。在首次咨询后的24小时内获得了血液样本,以评估常规实验室值以及与炎症(PAPP-A,肽素,CRP),内皮激活(MPO,弹性蛋白酶-2,内皮素-1,sICAM-1,sVCAM)相关的标志物-1),心脏功能(NT-proBNP,MR-proANP),凝血(纤维蛋白原,D-二聚体,血小板计数)和溶血(LDH)。使用接收器工作特征曲线(曲线下面积= AUROC)评估预后性能。结果十二名(15.2%)患者患有严重的恶性疟原虫疟疾。在患者组中,发现了明显的血小板减少症,除PAPP-A以外的所有其他标记均显着升高。对于CRP,AUROC为1.00的诊断性能最好,其次是MPO(0.99),D-二聚体(0.98),弹性蛋白酶2(0.98)和sICAM-1(0.98)。生物标志物水平与疾病严重程度没有很好的相关性。结论出行史,采血前发烧以及入院后CRP血清水平高于或低于10.8 mg / l的综合考虑,可以最好地区分疟疾患者和对照组。所研究的生物标记物均未预测入院时或住院期间疟疾并发症的存在或发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号